Imagine a tiny, flexible spring made of a special metal that acts like a gentle brace for the prostate. Instead of invasive surgery or lifelong pills, a doctor can slide this implant in during a quick office visit to open up the urine path. It works like a small support beam that keeps the channel open without any cutting or burning.
BPH treatments currently force a choice between ineffective drugs with side effects or invasive surgeries that require expensive hospital stays and long recovery times.
A Nitinol prostate implant and a 22French disposable delivery system that allows for a 4-8 minute office-based procedure.
If you are a manufacturer dealing with the high cost and complexity of surgical BPH tools — this project developed a Nitinol implant that can be deployed in under 4 minutes. This shifts the procedure from the operating room to a simple clinic setting.
If you are a clinic owner dealing with limited operating room access and high patient turnover — this project developed a device that allows BPH treatment under local anesthesia in the office. This reduces the need for hospitalization and expensive OR time.
If you are a payer dealing with the indefinite costs of BPH medication and expensive hospitalizations — this project developed a fully reversible implant. This reduces long-term drug costs and eliminates the high overhead of traditional surgery.
Based on available project data, specific pricing is not mentioned, but the device is designed as a fully disposable delivery system to reduce capital equipment investment.
The project focuses on a low profile (22French) fully disposable delivery system, indicating a shift toward high-volume, single-use manufacturing.
The technology is protected by 3 granted patents and has already achieved a CE mark.
The project aims to gain FDA and MDR approvals through pivotal trials involving 222 patients across 20 EU and US hospitals.
The project period runs from 2023-09-01 to 2025-08-31, with the current focus on completing pivotal trials.
The project is led by a single Israeli SME, Butterfly Medical Ltd. This 100% industry-led consortium indicates a high drive for commercialization and a streamlined decision-making process, avoiding the typical delays of academic-industrial partnerships.
Contact Butterfly Medical Ltd in Israel for licensing or partnership inquiries.
Contact us to explore partnership opportunities with Butterfly Medical for US/EU market entry.
